Patents by Inventor Jeanne-Marie Josephine DEVASTER

Jeanne-Marie Josephine DEVASTER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220023409
    Abstract: The present invention relates to immunogenic compositions comprising an immunogenic polypeptide from Haemophilus influenzae or an immunogenic fragment thereof and/or an immunogenic polypeptide from Moraxella catarrhalis or an immunogenic fragment thereof, for use in the treatment or prevention of a recurrence of an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) resulting from a bacterial infection in a subject.
    Type: Application
    Filed: October 12, 2021
    Publication date: January 27, 2022
    Applicants: GLAXOSMITHKLINE BIOLOGICALS SA, GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Catherine COHET, Jeanne-Marie Josephine DEVASTER, David MAYHEW, Bruce MILLER, Ruth TAL-SINGER, Vincent WEYNANTS, Thomas WILKINSON
  • Patent number: 11167022
    Abstract: The present invention relates to immunogenic compositions comprising an immunogenic polypeptide from Haemophilus influenzae or an immunogenic fragment thereof and/or an immunogenic polypeptide from Moraxella catarrhalis or an immunogenic fragment thereof, for use in the treatment or prevention of a recurrence of an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) resulting from a bacterial infection in a subject.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: November 9, 2021
    Assignees: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED, GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Catherine Cohet, Jeanne-Marie Josephine Devaster, David Mayhew, Bruce Miller, Ruth Tal-Singer, Vincent Weynants, Thomas Wilkinson
  • Publication number: 20200046823
    Abstract: The present invention relates to immunogenic compositions comprising an immunogenic polypeptide from Haemophilus influenzae or an immunogenic fragment thereof and/or an immunogenic polypeptide from Moraxella catarrhalis or an immunogenic fragment thereof, for use in the treatment or prevention of a recurrence of an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) resulting from a bacterial infection in a subject.
    Type: Application
    Filed: March 29, 2018
    Publication date: February 13, 2020
    Inventors: Catherine COHET, Jeanne-Marie Josephine DEVASTER, David MAYHEW, Bruce MILLER, Ruth TAL-SINGER, Vincent WEYNANTS, Thomas WILKINSON